2022
DOI: 10.3390/ijms231911590
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic and Immunological Role of STK38 across Cancers: Friend or Foe?

Abstract: Although STK38 (serine-threonine kinase 38) has been proven to play an important role in cancer initiation and progression based on a series of cell and animal experiments, no systemic assessment of STK38 across human cancers is available. We firstly performed a pan-cancer analysis of STK38 in this study. The expression level of STK38 was significantly different between tumor and normal tissues in 15 types of cancers. Meanwhile, a prognosis analysis showed that a distinct relationship existed between STK38 exp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 45 publications
(49 reference statements)
0
7
0
Order By: Relevance
“…Within the TME, immune cell and stromal cell play important roles, emerging as crucial prognostic biomarkers for cancer patients [13]. Quantitative scores obtained from ImmuneScore and StromalScore provide insights into the proportion of immune and stromal components, while ESTIMATEScore provides both aspects.…”
Section: Immune Subtype and Tumor Microenvironment (Tme) Analysis Of ...mentioning
confidence: 99%
“…Within the TME, immune cell and stromal cell play important roles, emerging as crucial prognostic biomarkers for cancer patients [13]. Quantitative scores obtained from ImmuneScore and StromalScore provide insights into the proportion of immune and stromal components, while ESTIMATEScore provides both aspects.…”
Section: Immune Subtype and Tumor Microenvironment (Tme) Analysis Of ...mentioning
confidence: 99%
“…Tumor mutation burden (TMB) serves as a crucial metric, representing the cumulative count of somatic coding mutation within a specific cancer type. This metric stands as a significant determinant of the efficacy of immunotherapy in various human cancer types 11 . Alteration data of all TCGA patients were downloaded from the UCSC XENA database.…”
Section: Analysis Of Tumor Mutation Burden and Microsatellite Instabi...mentioning
confidence: 99%
“…These properties are reported to result not from the function of Kir2.1 as an ion channel but from its interaction with STK38 to inhibit ubiquitination and degradation of MEKK2, thereby enhancing MEKK2-MEK1/2-ERK1/2 (extra-cellular signal-regulated kinase 1/2) signaling cascade [ 65 ] ( Figure 2 ). Recently, a pan-cancer analysis of STK38 reveals that the expression of STK38 is associated with patient survival, immune cell infiltration such as NK cells, cancer-associated fibroblasts, tumor mutation burden and microsatellite instability in several human cancers [ 66 ]. However, there is also evidence that STK38 can reduce the cell proliferation of glioblastomas and inhibit the metastasis of prostate cancer [ 67 ].…”
Section: Involvement Of Stk38 In Malignancymentioning
confidence: 99%